Back to Journals » OncoTargets and Therapy » Volume 9

Comparison of the effectiveness and toxicity of neoadjuvant chemotherapy regimens, capecitabine/epirubicin/cyclophosphamide vs 5-fluorouracil/epirubicin/cyclophosphamide, followed by adjuvant, capecitabine/docetaxel vs docetaxel, in patients with operable breast cancer

Total article views   HTML views PDF downloads Totals
8,911 Dovepress* 7,059+ 1,421 8,480
PubMed Central* 1,852 312 2,164
Totals 8,911 1,733 10,644
*Since 8 June 2016
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 1 1

View citations on PubMed Central and Google Scholar